Home

Rosszul érzi magát Visszatérítés Magányosság antiphospholipidmilyen cső Felújít Hozzászoktat Szétszór

JCM | Free Full-Text | Old and New Calcineurin Inhibitors in Lupus Nephritis
JCM | Free Full-Text | Old and New Calcineurin Inhibitors in Lupus Nephritis

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid

PDF) Non-criteria Antiphospholipid Antibodies: a narrative review
PDF) Non-criteria Antiphospholipid Antibodies: a narrative review

Frontiers | Genetic Polymorphisms and the Clinical Response to Systemic  Lupus Erythematosus Treatment Towards Personalized Medicine
Frontiers | Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid

Update on the Treatment of Systemic Lupus Erythematosus - Ana M Arango,  John D Reveille, 2006
Update on the Treatment of Systemic Lupus Erythematosus - Ana M Arango, John D Reveille, 2006

Mit jelent az ANA vizsgálat? | Gellért Labor - Vérvétel Budapesten,  magánlabor a Gellért téren
Mit jelent az ANA vizsgálat? | Gellért Labor - Vérvétel Budapesten, magánlabor a Gellért téren

Marcus, Author at DiaPharma
Marcus, Author at DiaPharma

Neutrophil Extracellular Traps May Augur Severe COVID-19 | The Scientist  Magazine®
Neutrophil Extracellular Traps May Augur Severe COVID-19 | The Scientist Magazine®

Treatment of lupus nephritis: consensus, evidence and perspectives | Nature  Reviews Rheumatology
Treatment of lupus nephritis: consensus, evidence and perspectives | Nature Reviews Rheumatology

PDF) Immunogenicity and safety after SARS-CoV-2 vaccine in Primary  Antiphospholipid Syndrome (PAPS)
PDF) Immunogenicity and safety after SARS-CoV-2 vaccine in Primary Antiphospholipid Syndrome (PAPS)

Frontiers | Thrombosis and Inflammation—A Dynamic Interplay and the Role of  Glycosaminoglycans and Activated Protein C
Frontiers | Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C

Blog: ALS vs MS vs Parkinson's Disease: The Differences Between Three  Common Neurodegenerative Diseases | ALS Therapy Development Institute
Blog: ALS vs MS vs Parkinson's Disease: The Differences Between Three Common Neurodegenerative Diseases | ALS Therapy Development Institute

Diagnosis and treatment of lupus nephritis. Consensus document from the  systemic auto-immune disease group (GEAS) of the Spanish Society of  Internal Medicine (SEMI) and the Spanish Society of Nephrology (S.E.N.) |  Nefrología
Diagnosis and treatment of lupus nephritis. Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Nephrology (S.E.N.) | Nefrología

Cureus | A Case of Acute Granulomatous Conjunctivitis Caused by  Cat-transmitted Sporothrix schenckii | Article
Cureus | A Case of Acute Granulomatous Conjunctivitis Caused by Cat-transmitted Sporothrix schenckii | Article

Savino Sciascia (@SavinoSciascia) / Twitter
Savino Sciascia (@SavinoSciascia) / Twitter

Savino Sciascia (@SavinoSciascia) / Twitter
Savino Sciascia (@SavinoSciascia) / Twitter

T sejtek és kemokinek változásának vizsgálata SLE pulmonalis  manifesztációjában Doktori értekezés Dr.Vincze Krisztina
T sejtek és kemokinek változásának vizsgálata SLE pulmonalis manifesztációjában Doktori értekezés Dr.Vincze Krisztina

PDF) Non-criteria Antiphospholipid Antibodies: a narrative review
PDF) Non-criteria Antiphospholipid Antibodies: a narrative review

Biomedicines | November 2022 - Browse Articles
Biomedicines | November 2022 - Browse Articles

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid

Savino Sciascia (@SavinoSciascia) / Twitter
Savino Sciascia (@SavinoSciascia) / Twitter

Logistic regression predicting those with >80% time in therapeutic range |  Download Table
Logistic regression predicting those with >80% time in therapeutic range | Download Table

COVID-19 Breaking News! French Study Confirms Previous Coronavirus Immunity  Offers No Protection Against SARS-CoV-2 - Thailand Medical News
COVID-19 Breaking News! French Study Confirms Previous Coronavirus Immunity Offers No Protection Against SARS-CoV-2 - Thailand Medical News

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid